International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 4 , Pages 1100-1107 , 15 March 2008

Intensity-Modulated Radiotherapy for Head and Neck Cancer of Unknown Primary: Toxicity and Preliminary Efficacy

  • Michelle L. Klem, M.D.

      Affiliations

    • Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
    • Corresponding Author InformationReprint requests to: Michelle Lee Klem, M.D., Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10022
    • ,
  • James G. Mechalakos, Ph.D.

      Affiliations

    • Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Suzanne L. Wolden, M.D.

      Affiliations

    • Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Michael J. Zelefsky, M.D.

      Affiliations

    • Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Bhuvanesh Singh, M.D., Ph.D.

      Affiliations

    • Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Dennis Kraus, M.D.

      Affiliations

    • Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Ashok Shaha, M.D.

      Affiliations

    • Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Jatin Shah, M.D.

      Affiliations

    • Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • David G. Pfister, M.D.

      Affiliations

    • Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Nancy Y. Lee, M.D.

      Affiliations

    • Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

Received 26 February 2007 ,Revised 25 June 2007 ,Accepted 25 July 2007.

References 

  1. Sinnathamby K, Peters LJ, Laidlaw C, et al. The occult head and neck primary: To treat or not to treat?. Clin Oncol (R Coll Radiol). 1997;9:322–329
  2. Grau C, Johansen LV, Jakobsen J, et al. Cervical lymph node metastases from unknown primary tumours: Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol. 2000;55:121–129
  3. Fogarty GB, Peters LJ, Stewart J, et al. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck. 2003;25:138–145
  4. Miller FR, Hussey D, Beeram M, et al. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2005;131:626–629
  5. Regelink G, Brouwer J, de Bree R, et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: Value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging. 2002;29:1024–1030
  6. Stoeckli SJ, Mosna-Firlejczyk K, Goerres GW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: Impact of positron emission tomography. Eur J Nucl Med Mol Imaging. 2003;30:411–416
  7. Wong WL, Saunders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol). 2003;15:461–466
  8. Johansen J, Eigtved A, Buchwald C, et al. Implication of 18F-fluoro-2-deoxy-d-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: A Danish cohort study. Laryngoscope. 2002;112:2009–2014
  9. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7–16
  10. Nieder C, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma. Curr Treat Options Oncol. 2002;3:33–40
  11. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls. J Clin Oncol. 2006;24:2618–2623
  12. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12–22
  13. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312–321
  14. Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume. Int J Radiat Oncol Biol Phys. 2004;59:43–50
  15. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28–42
  16. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69–76
  17. Weir L, Keane T, Cummings B, et al. Radiation treatment of cervical lymph node metastases from an unknown primary: An analysis of outcome by treatment volume and other prognostic factors. Radiother Oncol. 1995;35:206–211
  18. Nieder C, Gregoire V, Ang KK. Cervical lymph node metastases from occult squamous cell carcinoma: Cut down a tree to get an apple?. Int J Radiat Oncol Biol Phys. 2001;50:727–733
  19. Coster JR, Foote RL, Olsen KD, et al. Cervical nodal metastasis of squamous cell carcinoma of unknown origin: Indications for withholding radiation therapy. Int J Radiat Oncol Biol Phys. 1992;23:743–749
  20. Reddy SP, Marks JE. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: Results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation. Int J Radiat Oncol Biol Phys. 1997;37:797–802
  21. Marcial-Vega VA, Cardenes H, Perez CA, et al. Cervical metastases from unknown primaries: Radiotherapeutic management and appearance of subsequent primaries. Int J Radiat Oncol Biol Phys. 1990;19:919–928
  22. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–587
  23. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report. Int J Radiat Oncol Biol Phys. 2005;63:725–731
  24. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798–1804
  25. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–2098
  26. Argiris A, Smith SM, Stenson K, et al. Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol. 2003;14:1306–1311
  27. de Braud F, Heilbrun LK, Ahmed K, et al. Metastatic squamous cell carcinoma of an unknown primary localized to the neck: Advantages of an aggressive treatment. Cancer. 1989;64:510–515
  28. Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg. 2003;27:832–837

 Conflict of interest: none.

PII: S0360-3016(07)03702-9

doi: 10.1016/j.ijrobp.2007.07.2351

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 4 , Pages 1100-1107 , 15 March 2008

Article Tools

* Image Usage & Resolution